Stock Events

Stock Events

Search...

Fate Therapeutics (FATE) Q4 2024 Earnings

12NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.52

-0.46

-0.39

-0.33

Details

Expected EPS

-0.416457

Actual EPS

-0.4

Surprise EPS

0.02

Surprise Percent

+3.95%

Description

Fate Therapeutics (FATE) has reported earnings of -0.4 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.